Categories
Change Password!
Reset Password!
EMA issues flu vaccine composition guidance for 20...
AGA releases best practice advice for managing exo...
The American Gastroenterological Association (AGA) has issued a new Clinical Practice Update offering vital guidance on the diagnosis and managem...
Study confirms modified bismuth quadruple therapy...
In the face of rising Helicobacter pylori (H. pylori) elimination failure, a new systematic review and meta-analysis offers promising evidence th...
Microneedling + minoxidil boosts hair regrowth in...
In a systematic review and meta-analysis, combining microneedling with minoxidil offered markedly better outcomes for individuals with androgenet...
Reddy’s and Henlius collaborate to commercialize d...
On 6 February 2025, Dr. Reddy’s Laboratories SA (Société Anonyme, a French term meaning "public limited company), a whol...
Dr. Reddy’s and Bio-Thera forge strategic alliance...
As per the notification published on 26 March 2025, Dr. Reddy’s Laboratories Ltd., a global pharmaceutical leader based in India, has enter...
New FDA-approved medication for hemophilia offers...
In a major advancement for hemophilia care on 28 March 2025, the Food and Drug Administration (FDA) has granted approval to fitusiran (small inte...
Sanofi and Dr. Reddy’s partner to introduce RSV pr...
On 28 April 2025, Dr. Reddy’s Laboratories Ltd. announced an exclusive distribution agreement with Sanofi Healthcare India Pvt. Ltd. for th...
Bempedoic acid shows strong LDL-C lowering effects...
A recent phase 3 clinical trial conducted in Japan, known as the CLEAR-J study, has illustrated that bempedoic acid is an effective, safe, and we...
Glycemic benefits of adding vildagliptin to premix...
Type 2 diabetes mellitus (T2DM) patients undergoing premixed insulin therapy often struggle to maintain optimal glycemic control.
Real-world effectiveness of BA vs. BA + ezetimibe...
Bempedoic acid (BA), an adenosine triphosphate-citrate lyase inhibitor, has been proven in randomized clinical trials to substantially reduce low...
Pre-wake fractal activity patterns as a novel biom...
Subtle alterations in rest-activity patterns during adolescence and young adulthood highlight early warning signs of depression, offering potenti...
Novel predictor of inhaled corticosteroid effectiv...
For chronic obstructive pulmonary disease (COPD), inhaled corticosteroids (ICS) are a cornerstone therapy.
Liquid platelet-rich fibrin as an adjunct to arthr...
This study evaluated the usefulness of liquid platelet-rich fibrin (liquid PRF) in temporomandibular disorders (TMD).
Comparative efficacy of nutritional supplements in...
Nutritional supplements play a crucial role in alleviating polycystic ovary syndrome (PCOS) by influencing endocrine balance, metabolic function,...
Tegoprazan matches PPI healing rates in erosive es...
GLP-1 therapies show strongest preoperative weight...
New research from the University of Oklahoma-Tulsa Comprehensive Weight Loss and Bariatric Surgery Program shows that glucagon-like peptide-1 (GL...
Which hidden barriers prevent effective treatment...
Chronic spontaneous urticaria (CSU) is a long-standing skin condition marked by recurrent hives and angioedema without a known cause, often disru...
Real-world data raise concerns over PPI safety in...
Proton pump inhibitors (PPIs) are commonly prescribed to manage gastric acid disorders (like gastroesophageal reflux disease [GERD]) in neonates...
Ketorolac relieves pain during photodynamic therap...
As per the outcomes of a clinical study, combining ketorolac tromethamine with a two-step irradiation protocol during 5-aminolevulinic acid photo...
Global analysis reveals modern lifestyle factors b...
A new global study has revealed substantial disparities in atopic dermatitis (AD) incidence across 204 countries between 1990 and 2021. The resea...
Droplet digital PCR offers accurate prediction of...
Helicobacter pylori (H. pylori) continues to pose a global health concern as a major cause of peptic ulcers and gastric cancer while escalating c...
Do men and women benefit differently from physical...
Hypertension, hyperlipidemia, and hyperglycemia remain key risk factors for cardiovascular disease (CVD)—the second predominant cause of de...
Tegoprazan outperforms lansoprazole in healing ero...
A multicenter clinical trial has revealed that tegoprazan, a novel potassium-competitive acid blocker (P-CAB), is not only non-inferior but also...
Aeroallergen sensitization identified as key contr...
Chronic spontaneous urticaria (CSU) — a persistent skin ailment marked by recurrent hives and itching — remains a puzzling allergic d...
